Katherine J. Klein - 08 Mar 2024 Form 4 Insider Report for UNITED THERAPEUTICS Corp (UTHR)

Role
Director
Signature
John S. Hess, Jr. under Power of Attorney
Issuer symbol
UTHR
Transactions as of
08 Mar 2024
Net transactions value
-$1,168,066
Form type
4
Filing time
11 Mar 2024, 16:30:33 UTC
Previous filing
17 Jul 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UTHR Common Stock Options Exercise $1,211,636 +9,791 +269% $123.75 13,431 08 Mar 2024 Direct F1
transaction UTHR Common Stock Disposed to Issuer $2,379,703 -9,791 -73% $243.05 3,640 08 Mar 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UTHR Share Tracking Award Options Exercise $0 -9,791 -33% $0.000000 19,584 08 Mar 2024 Common Stock 9,791 $123.75 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.